GO:0002309 T cell proliferation involved in immune response: Immune Expansion Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002309 describes the clonal expansion of T cells by cell division as part of an immune response, a process essential for adaptive immunity.
• T cell proliferation is initiated by antigen recognition through the T cell receptor (TCR) and requires costimulation and cytokine signals.
• Key genes driving this process include IL2, CD28, MYC, and mTOR pathway components, which regulate cell cycle entry and survival.
• Dysregulated T cell proliferation contributes to autoimmune diseases, immunodeficiencies, and cancer.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of genes controlling T cell expansion.
• Understanding this GO term aids development of immunotherapies, vaccines, and treatments for immune disorders.
Description
T cell proliferation involved in immune response (GO:0002309) is a fundamental biological process that enables the adaptive immune system to mount effective defenses against pathogens. Upon antigen recognition, naive T cells undergo clonal expansion, generating a large population of effector cells capable of eliminating infected or malignant cells. This process is tightly regulated by a network of signaling pathways, transcription factors, and cytokines that ensure appropriate magnitude and duration of the response. Researchers study GO:0002309 to understand immune activation, tolerance, and the pathogenesis of immune-related diseases. Dysregulation of T cell proliferation underlies autoimmune conditions, immunodeficiency, and cancer progression, making it a critical area of biomedical research. Advances in CRISPR gene editing have provided powerful tools to interrogate the genetic control of T cell expansion, offering insights into basic immunology and therapeutic development.
T cell proliferation involved in immune response At A Glance
| GO ID | GO:0002309 |
|---|---|
| GO term | T cell proliferation involved in immune response |
| Ontology | biological_process |
| Synonym | T cell proliferation during immune response; T-cell proliferation during immune response; T lymphocyte proliferation during immune response; T-lymphocyte proliferation during immune response |
| Major function | Clonal expansion of T cells by cell division as part of an immune response |
| Related processes | T cell activation, cytokine signaling, cell cycle regulation |
| Key regulators | TCR, CD28, IL-2, mTOR, MYC |
| Disease relevance | Autoimmunity, immunodeficiency, cancer, infectious diseases |
What Is GO:0002309?
GO:0002309, T cell proliferation involved in immune response, is defined as the expansion of a T cell population by cell division as part of an immune response. This process encompasses the series of molecular and cellular events that lead to the clonal multiplication of T lymphocytes following antigenic stimulation, a hallmark of adaptive immunity.
Why Is T cell proliferation involved in immune response Important in Cell Biology?
T cell proliferation involved in immune response is central to adaptive immunity, as it determines the magnitude and effectiveness of the immune response against pathogens and tumors. Defects in this process lead to immunodeficiency, while excessive proliferation contributes to autoimmunity and lymphoproliferative disorders. Understanding the molecular mechanisms governing T cell expansion is essential for developing vaccines, immunotherapies, and treatments for immune-mediated diseases.
• Enables clonal expansion of antigen-specific T cells for effective pathogen clearance.
• Underpins immunological memory formation and long-term protection.
• Dysregulation causes autoimmune diseases such as rheumatoid arthritis and type 1 diabetes.
• Impaired proliferation leads to immunodeficiency and increased susceptibility to infections.
• Plays a role in antitumor immunity and cancer immunotherapy responses.
• Serves as a target for immunosuppressive therapies in transplantation.
• Involved in immune responses to intracellular pathogens like Mycobacterium tuberculosis.
• Provides a model for studying cell cycle control and signal transduction.
• Critical for vaccine development and evaluation of adjuvants.
• Offers insights into T cell exhaustion in chronic infections and cancer.
What Happens During T cell proliferation involved in immune response?
Antigen Recognition and T Cell Activation
In simple terms: T cells recognize foreign particles and get activated.
T cell proliferation begins with the recognition of antigen presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The T cell receptor (TCR) binds to the peptide-MHC complex, triggering intracellular signaling cascades that lead to T cell activation. This initial activation event is accompanied by costimulatory signals, such as CD28 binding to B7 molecules, which are required for full activation and subsequent proliferation.
Signal Transduction and Early Gene Response
In simple terms: Activation sends signals that turn on genes needed for division.
Upon TCR engagement, downstream signaling pathways including the MAPK, NF-κB, and calcium-calcineurin pathways are activated. These pathways induce the expression of early response genes such as IL2, CD69, and MYC, which drive the transition from G0 to G1 phase of the cell cycle. The early gene response is critical for committing T cells to proliferation and effector function.
Cytokine-Driven Clonal Expansion
In simple terms: Growth factors tell T cells to multiply.
Activated T cells produce and respond to interleukin-2 (IL-2), a key cytokine that promotes survival, proliferation, and differentiation. IL-2 signaling through the IL-2 receptor activates the JAK-STAT and PI3K-AKT-mTOR pathways, leading to cell cycle progression and clonal expansion. Other cytokines such as IL-7 and IL-15 also contribute to T cell proliferation under specific conditions.
Metabolic Reprogramming and Cell Cycle Entry
In simple terms: T cells change their metabolism to support rapid growth.
Proliferating T cells undergo metabolic reprogramming towards aerobic glycolysis and glutaminolysis to meet the biosynthetic demands of rapid division. The mTOR pathway plays a central role in this metabolic switch, integrating nutrient and growth factor signals to promote cell cycle entry and progression. MYC and HIF1A are key transcription factors that regulate metabolic gene expression during T cell proliferation.
Regulation of Proliferation and Contraction
In simple terms: The immune response is turned off after the threat is cleared.
Following antigen clearance, the expanded T cell population undergoes contraction via apoptosis, leaving a small pool of memory T cells. This contraction is regulated by pro-apoptotic factors such as BIM and by cytokines like IL-2 and TGF-β, which limit excessive proliferation and prevent autoimmunity. Regulatory T cells also suppress T cell proliferation to maintain immune homeostasis.
Key Genes Involved in GO:0002309 T cell proliferation involved in immune response
The following genes and proteins are critically involved in the regulation and execution of T cell proliferation involved in immune response.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2 | Cytokine that promotes T cell proliferation and survival | Target for immunosuppression and immunotherapy |
| IL2RA | Alpha chain of IL-2 receptor, high-affinity binding | Marker of activated T cells; target in autoimmunity |
| CD28 | Costimulatory receptor providing second signal for activation | Target for T cell activation modulation |
| CTLA4 | Inhibitory receptor that dampens T cell activation | Checkpoint target in cancer immunotherapy |
| MYC | Transcription factor driving cell cycle and metabolism | Oncogene; regulates proliferation |
| MTOR | Kinase integrating growth signals for proliferation | Target of rapamycin; immunosuppressant |
| PIK3CA | Catalytic subunit of PI3K, activates AKT | Frequently mutated in cancers |
| AKT1 | Serine/threonine kinase promoting survival and proliferation | Key node in signaling |
| MAPK1 | Kinase in MAPK pathway downstream of TCR | Regulates gene expression |
| NFKB1 | Transcription factor activated by TCR signaling | Controls survival and proliferation genes |
| STAT5A | Transcription factor downstream of IL-2 receptor | Essential for T cell proliferation |
| FOXP3 | Transcription factor for regulatory T cells | Suppresses excessive proliferation |
| BIM (BCL2L11) | Pro-apoptotic factor limiting expansion | Regulates contraction phase |
| CD69 | Early activation marker | Indicator of T cell activation |
| HIF1A | Transcription factor for hypoxia and metabolism | Supports metabolic reprogramming |
| TGFB1 | Cytokine inhibiting T cell proliferation | Regulates immune tolerance |
| IL7R | Receptor for IL-7, promotes survival and proliferation | Target in immunodeficiency |
How Is T cell proliferation involved in immune response Regulated?
T cell proliferation involved in immune response is tightly regulated at multiple levels. Positive regulators include TCR signaling, costimulation via CD28, and cytokine signals such as IL-2, which activate the PI3K-AKT-mTOR and JAK-STAT pathways. Negative regulators include CTLA-4, PD-1, and TGF-β, which inhibit T cell activation and proliferation to prevent autoimmunity. Regulatory T cells (Tregs) also suppress proliferation through contact-dependent and cytokine-mediated mechanisms. The balance between these signals determines the magnitude and duration of the immune response.
T cell proliferation involved in immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL2RA | Autoimmunity, immunodeficiency | Knockout mouse or human T cells |
| CTLA4 | Autoimmune lymphoproliferative syndrome | Knock-in mouse models |
| FOXP3 | IPEX syndrome, autoimmunity | Knockout mice |
| MTOR | Cancer, autoimmunity | Conditional knockout |
| IL2RG | Severe combined immunodeficiency | Knockout humanized mice |
Autoimmune Diseases
Dysregulated T cell proliferation is a hallmark of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. In these conditions, T cells escape tolerance mechanisms and proliferate excessively, leading to tissue damage. Autophagy defects in T cells have been linked to autoimmune pathogenesis, highlighting the interplay between cellular stress responses and proliferation.
Immunodeficiency
Impaired T cell proliferation results in immunodeficiency, characterized by increased susceptibility to infections. Mutations in genes essential for T cell activation or proliferation, such as IL2RG, can cause severe combined immunodeficiency (SCID). Understanding the genetic basis of these disorders is critical for diagnosis and therapy.
Cancer
T cell proliferation is central to antitumor immunity, and its enhancement is a goal of cancer immunotherapy. Checkpoint inhibitors like anti-CTLA-4 and anti-PD-1 block inhibitory signals, thereby promoting T cell proliferation and tumor rejection. Conversely, uncontrolled proliferation can lead to T cell lymphomas and leukemias.
Infectious Diseases
Effective T cell proliferation is required for control of intracellular pathogens such as Mycobacterium tuberculosis. The Vγ2Vδ2 T cell subset expands during M. tuberculosis infection and contributes to protective immunity. Similarly, T cell clones with mixed Th1/Th2 responses are observed in parasitic infections like trichinellosis.
From T cell proliferation involved in immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate T cell proliferation? | CRISPR knockout in primary T cells or Jurkat cells |
| What is the effect of a point mutation in gene Y on T cell expansion? | CRISPR point mutation knock-in in T cells |
| How does overexpression of gene Z affect T cell proliferation? | Lentiviral overexpression in primary T cells |
| What is the role of a specific protein domain in T cell proliferation? | CRISPR knock-in of tagged protein |
| Can we identify novel regulators of T cell proliferation? | Genome-wide CRISPR library screening |
| How does a disease-associated SNP affect T cell proliferation? | CRISPR knock-in of SNP in T cells |
How to Study the T cell proliferation involved in immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Cell division, surface markers | Quantify proliferation and activation |
| RNA-seq | Transcriptome changes | Identify gene expression programs |
| CRISPR screen | Gene function in proliferation | Discover novel regulators |
| Proteomics | Protein abundance and modifications | Map signaling pathways |
| ELISA | Cytokine secretion | Measure IL-2, IFN-γ production |
| Western blot | Protein expression and phosphorylation | Validate signaling events |
| Immunofluorescence | Protein localization and activation | Visualize NF-κB nuclear translocation |
Flow Cytometry
Flow cytometry is widely used to measure T cell proliferation by tracking dilution of fluorescent dyes such as CFSE or by detecting proliferation markers like Ki-67. This method allows quantification of cell division at the single-cell level and assessment of surface markers.
RNA Sequencing (RNA-seq)
RNA-seq provides a comprehensive view of gene expression changes during T cell activation and proliferation. It can identify early response genes, signaling pathways, and regulatory networks that drive clonal expansion.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens enable unbiased discovery of genes that regulate T cell proliferation. These screens can be performed in primary T cells or cell lines and coupled with next-generation sequencing to identify enriched or depleted sgRNAs.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein expression and phosphorylation changes during T cell proliferation, revealing signaling events downstream of TCR and cytokine receptors.
How CRISPR Can Be Used to Study GO:0002309 T cell proliferation involved in immune response
Knockout
CRISPR knockout is used to completely ablate the expression of genes suspected to regulate T cell proliferation. By introducing indels in early exons, researchers can assess loss-of-function phenotypes in primary T cells or cell lines, providing causal evidence for gene function.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated or functional SNPs into the genome. This approach is valuable for studying how single nucleotide changes affect T cell proliferation and signaling, mimicking human genetic variants.
Knock-in
Knock-in of reporter genes, tags, or humanized sequences enables tracking of protein expression, localization, and interactions. For example, knocking in a fluorescent tag into the IL2 locus allows real-time monitoring of IL-2 production during T cell activation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive supraphysiological expression of candidate genes to test gain-of-function effects on T cell proliferation. This is particularly useful for studying oncogenes or constitutively active signaling molecules.
How EDITGENE Supports T cell proliferation involved in immune response Research
Researchers studying T cell proliferation involved in immune response-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of T cell biology.
Contact EDITGENE today to design your custom CRISPR model for T cell proliferation involved in immune response research.
Frequently Asked Questions About T cell proliferation involved in immune response
What is GO:0002309?
GO:0002309 is the Gene Ontology term for T cell proliferation involved in immune response, defined as the expansion of a T cell population by cell division as part of an immune response.
What genes are involved in T cell proliferation involved in immune response?
Key genes include IL2, CD28, MYC, MTOR, and STAT5A, which regulate activation, signaling, and cell cycle progression.
How is T cell proliferation measured?
Common methods include flow cytometry with CFSE dilution, Ki-67 staining, and RNA-seq to track gene expression changes.
What diseases are associated with abnormal T cell proliferation?
Autoimmune diseases, immunodeficiencies, and cancers are linked to dysregulated T cell proliferation.
What is the role of IL-2 in T cell proliferation?
IL-2 is a cytokine that promotes T cell survival, proliferation, and effector function through the IL-2 receptor and downstream JAK-STAT and mTOR pathways.
How does CRISPR help study T cell proliferation?
CRISPR enables knockout, knock-in, point mutation, and overexpression of genes to determine their causal role in T cell proliferation.
What are the stages of T cell proliferation?
Stages include antigen recognition, signal transduction, cytokine-driven expansion, metabolic reprogramming, and contraction.
Can T cell proliferation be inhibited therapeutically?
Yes, immunosuppressants like rapamycin and checkpoint inhibitors modulate T cell proliferation in autoimmune diseases and transplantation.
What is the difference between T cell activation and proliferation?
Activation is the initial response to antigen, while proliferation is the subsequent clonal expansion driven by growth factors.
How does mTOR regulate T cell proliferation?
mTOR integrates nutrient and growth factor signals to promote metabolic reprogramming and cell cycle entry in T cells.
Conclusion
T cell proliferation involved in immune response (GO:0002309) is a cornerstone of adaptive immunity, enabling the expansion of antigen-specific T cells to combat infections and tumors. Its precise regulation is critical for immune homeostasis, and its dysregulation contributes to a wide range of diseases. Advances in CRISPR technology and functional genomics have greatly enhanced our ability to dissect the genetic and molecular control of this process. Continued research into GO:0002309 will inform the development of novel immunotherapies and vaccines.
References
- 1. Galaine J et al.. 2016. Pour comprendre : l’activation lymphocytaire T.. Bull Cancer 103 Suppl 1:S127-S131 PMID: 28057175
- 4. Mortlock SA et al.. 2015. T-cell activation and early gene response in dogs.. PLoS One 10(3):e0121169 PMID: 25803042
- 5. Della Bella C et al.. 2017. T-cell clones in human trichinellosis: Evidence for a mixed Th1/Th2 response.. Parasite Immunol 39(3) PMID: 28106258
- 7. Chen ZW. 2016. Protective immune responses of major Vγ2Vδ2 T-cell subset in M. tuberculosis infection.. Curr Opin Immunol 42:105-112 PMID: 27491008
- 8. Zhao X et al.. 2024. Research progress of T cell autophagy in autoimmune diseases.. Front Immunol 15:1425443 PMID: 39104538
